{"entity":{"id":"navignostics","kind":"company","name":"Navignostics","aka":[],"tldr":"Navignostics maps dozens of proteins at single-cell resolution across one tumour section, showing which cells sit next to which immune cells, to guide personalised treatment.","summary":"Navignostics, a Zürich company, combines highly multiplexed tumour imaging with data analytics: spatial single-cell proteomic analysis of a single formalin-fixed section captures tumour and immune cell types and their interactions. Future of Cancer Care Today lists it for both molecular and immune profiling, physician-ordered through an early-access partner programme.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.navignostics.com/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["ctgov-sponsor","fcct-directory"],"related":[],"cancers":[],"sections":[],"technologies":["imaging-mass-cytometry","spatial-transcriptomics","multiplex-immunofluorescence"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Zürich, Switzerland","country":"CH","companyType":"diagnostics","website":"https://www.navignostics.com/","investors":[],"funding":[]},"route":"/companies/navignostics/","neighbours":{"technology":[{"id":"imaging-mass-cytometry","kind":"technology","name":"Imaging mass cytometry","route":"/technologies/imaging-mass-cytometry/"},{"id":"multiplex-immunofluorescence","kind":"technology","name":"Multiplex immunofluorescence","route":"/technologies/multiplex-immunofluorescence/"},{"id":"spatial-transcriptomics","kind":"technology","name":"Spatial transcriptomics","route":"/technologies/spatial-transcriptomics/"}]}}